Management of radiation oncology patients with implanted cardiac pacemakers: report of AAPM Task Group No. 34. American Association of Physicists in Medicine.
Management of radiation oncology patients with implanted cardiac pacemakers: report of AAPM Task Group No. 34. American Association of Physicists in Medicine.
复制标题
植入心脏起搏器的放射肿瘤患者的管理：AAPM 工作组第 34 号报告。美国医学物理学家协会。
DOI：
--
复制
发表时间：
1994
期刊：
影响因子：
--
通讯作者：
A. Wolbarst
中科院分区：
文献类型：
--
作者：
J. Marbach;M. Sontag;J. V. Dyk;A. Wolbarst
当代心脏起搏器在低至10 gray的剂量下可因辐射损伤而失效，在低至2 gray的剂量下可表现出功能改变。本文对这一潜在问题进行了回顾和讨论，并提出了一种方案，建议对植入起搏器的患者进行放射治疗，以便将起搏器的累积剂量限制在2gray。虽然某些程度和类型的电磁干扰会导致起搏器故障，但有证据表明，这对大多数现代放射治疗设备来说并不是一个严重的问题。
Contemporary cardiac pacemakers can fail from radiation damage at doses as low as 10 gray and can exhibit functional changes at doses as low as 2 gray. A review and discussion of this potential problem is presented and a protocol is offered that suggests that radiation therapy patients with implanted pacemakers be planned so as to limit accumulated dose to the pacemaker to 2 gray. Although certain levels and types of electromagnetic interference can cause pacemaker malfunction, there is evidence that this is not a serious problem around most contemporary radiation therapy equipment.